South Africa's Competition Commission announced an investigation into three drug companies accused of over-charging for cancer medicines, according to a Reuters article.
Tembinkosi Bonakele, head of the Commission, said they would investigate Aspen Pharmacare, Africa's biggest generic drug manufacturer; New York-based Pfizer; and Swiss company Roche Holding.
The Commission investigates cases before bringing them to the Competition Tribunal for adjudication.
Read the full story